Evidence map›Paper›PMID 41310103›Full record

ArticleExperimental & molecular medicine2025

(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma.

Igor Shapiro, Huguette Debaix, Chiara Kräuchi, Andrea Abate, Stefan R Bornstein, Svenja Nölting, Samuel Gunz, Alfredo Berruti, Sandra Sigala, Felix Beuschlein and 2 more

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. WNT4 reprograms dental pulp stem cells to resist PANoptosis and rebuild neurogenic potential for facial nerve injury repair.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Igor Shapiro *Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Huguette Debaix *Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Chiara KräuchiDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Andrea AbateSection of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Stefan R BornsteinDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Svenja NöltingDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Samuel GunzDepartment of Computer Science, Institute for Machine Learning, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8909-0932
Alfredo BerrutiMedical Oncology Unit, Azienda Socio Sanitaria Territoriale Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Sandra SigalaSection of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Felix BeuschleinDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Edlira LucaDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland.
Constanze HantelDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zurich, Switzerland. Constanze.Hantel@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor cells rearrange cytoskeletal networks, harmonize signaling pathways and modulate cell fate to initiate tumor growth and metastasis. Activating mutations in the canonical Wnt-β-catenin pathway are associated with aggressiveness and poor prognosis in adrenocortical carcinoma (ACC). However, the contribution of noncanonical Wnt pathways, which are known to regulate cell polarity and migration, is still widely unknown. Here we comprehensively investigated canonical and noncanonical Wnt signaling along with cytoskeleton networks, stemness programs and HOX gene expression in recently developed 2D and 3D cultures of primary, local and distant metastatic ACC models. We report that tumor spheroids derived from nonmetastatic primary tumors correlated strongly with the overexpression of canonical Wnt signaling components, while metastatic ACC models demonstrated shifts toward noncanonical Wnt pathways together with perturbed expression of matrix-cytoskeleton-nucleoskeleton markers and related changes in the cytoarchitecture of respective tumor spheroids. Consistent with a potential noncanonical Wnt activation in the metastatic models, an abundance and relocalization of proteins associated with tumor aggressiveness such as β-catenin, β-actin, vimentin and nucleolin as well as specific HOX-cluster activation was detected, suggesting strong potential for specific reconfigurations of metastatic tumor niches. Furthermore, all models demonstrated key properties of cancer stem cells, although with varying degrees of expression of progenitor and stem cell markers, which could be dynamically modulated by treatments and therapies. Overall, our results draw parallels between canonical and noncanonical Wnt signaling, differential cytoskeletal remodeling, stemness properties and various cellular plasticities in primary tumor and metastasis-derived models of ACC.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaNeoplastic Stem CellsWnt Signaling Pathwaybeta CateninCell Line, TumorGene Expression Regulation, NeoplasticHumansNeoplasm MetastasisSpheroids, Cellularbeta Catenin

Identifiers

PMID41310103
PMCPMC12686465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.